Gene · 2122
Papers2,623
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,623
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic characterization of regulatory variants of blood pressure genes. | Cell Genom | 2023 | 37492106 | PubTator, text mining | PubMed |
| The Contribution of Multiplexing Single Cell RNA Sequencing in Acute Myeloid Leukemia. | Diseases | 2023 | 37489448 | PubTator, text mining | PubMed |
| Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. | J Ovarian Res | 2023 | 37460928 | PubTator, text mining | PubMed |
| Histone Variants and Their Chaperones in Hematological Malignancies. | Hemasphere | 2023 | 37449197 | PubTator, text mining | PubMed |
| Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors. | Cancers (Basel) | 2023 | 37444622 | PubTator, text mining | PubMed |
| Impact of Next-Generation Sequencing in Diagnosis, Prognosis and Therapeutic Management of Acute Myeloid Leukemia/Myelodysplastic Neoplasms. | Cancers (Basel) | 2023 | 37444390 | PubTator, text mining | PubMed |
| Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers. | Cells | 2023 | 37443779 | PubTator, text mining | PubMed |
| The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients. | Front Med (Lausanne) | 2023 | 37435533 | PubTator, text mining | PubMed |
| Inferring regulators of cell identity in the human adult pancreas. | NAR Genom Bioinform | 2023 | 37435358 | PubTator, text mining | PubMed |
| A signature of cuproptosis-related lncRNAs predicts prognosis and provides basis for future anti-tumor drug development in breast cancer. | Transl Cancer Res | 2023 | 37434691 | PubTator, text mining | PubMed |
| Evaluation of hypereosinophilia in a case of FLT3-mutant acute myeloid leukemia treated with gilteritinib. | Cold Spring Harb Mol Case Stud | 2023 | 37433680 | PubTator, text mining | PubMed |
| Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapy. | Front Cell Dev Biol | 2023 | 37427373 | PubTator, text mining | PubMed |
| Transcriptional Profile of Human Pancreatic Acinar Ductal Metaplasia. | Gastro Hep Adv | 2023 | 37425649 | PubTator, text mining | PubMed |
| A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents. | J Hematol Oncol | 2023 | 37422688 | PubTator, text mining | PubMed |
| Etiology of super-enhancer reprogramming and activation in cancer. | Epigenetics Chromatin | 2023 | 37415185 | PubTator, text mining | PubMed |
| MECOM Deficiency: from Bone Marrow Failure to Impaired B-Cell Development. | J Clin Immunol | 2023 | 37407873 | PubTator, text mining | PubMed |
| Potential new therapeutic targets: Association of microRNA with atherosclerotic plaque stability. | Int J Immunopathol Pharmacol | 2023 | 37403558 | PubTator, text mining | PubMed |
| Spatially resolved expression landscape and gene-regulatory network of human gastric corpus epithelium. | Protein Cell | 2023 | 37402315 | PubTator, text mining | PubMed |
| Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression. | BMC Cancer | 2023 | 37400764 | PubTator, text mining | PubMed |
| Proposal of a new genomic framework for categorization of pediatric acute myeloid leukemia associated with prognosis. | Res Sq | 2023 | 37398194 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2122/papers?page=13